NCT00427700 2024-08-21
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Hospital de Clinicas de Porto Alegre
Phase 3 Completed
Clinical Trials
12 trialsNCT01482286 2022-03-15
PULSE
Pennington Biomedical Research Center
Phase 3 Terminated
NCT03480022 2021-06-07
SAXAPCOS
Woman's
Phase 3 Completed
NCT02635386 2021-01-29
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Phase 3 Completed
NCT00747617 2018-11-21
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
University of California, San Diego
Phase 3 Completed
NCT01483118 2017-10-03
Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
Columbia University
Phase 3 Completed
NCT02328404 2016-08-04
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Hayat Pharmaceutical Co. PLC
Phase 3 Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT00283816 2015-05-15
Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
University of Rochester
Phase 3 Completed
NCT00714233 2015-05-15
Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)
University of Rochester
Phase 3 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01185782 2013-12-27
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed